Regions
Cleave Biosciences Raises Funding for Cancer Research
Cleave Biosciences raised US$10 million for its Series A financing. In an announcement, Cleave Biosciences said that it was able to raise for its Series A extension financing from new investor New Enterprise Associates.
Sea World's Shamu To Go Public
Sea World would be offered to the public via an IPO scheduled within the year. Sea World Parks and Entertainment, now owned by Blackstone Group LP, would be offering its shares at initial public offering at a price range between US$24 and US$27 per share.
Brazil's Infraero Withdraws IPO
Infraero has withdrawn its application for an IPO as two of its licenses to operate may provide the necessary funding for its operations and growth.
Steady Med Gets Loan from Square 1
A US$3 million loan was granted by Square 1 for the expansion goals of SteadyMed. Square 1 Bank has announced it has opened a US $3 million term loan credit facility to SteadyMed Therapeutics.